SAN DIEGO, CA--(Marketwire - July 27, 2009) -
Dr. Chong Yuan, Managing Director of Diazyme
Laboratories Division, General Atomics, received the 2009 Pacific
Biometrics Research Foundation Award at the annual meeting of American
Association for Clinical Chemistry (AACC) held in Chicago on July 20th,
The Award was presented to Dr. Yuan by Dr. George Casko, Chairman of
Lipoprotein and Vascular Disease Division, in recognition of Dr. Yuan's
outstanding contribution to scientific research in clinical chemistry and
his innovation in developing an enzyme cycling based clinical diagnostic
test for blood levels of Homocysteine (Hcy), an emerging independent risk
factor for cardiovascular disease and stroke.
"Recent clinical studies showed that the risk for stroke increases 14 fold
for patients with both high blood pressure and high blood Hcy in comparison
with patients without either of them, and an accurate and easy to use Hcy
test will play a key role in stroke prevention, especially for those with
hypertension," said Dr. Yuan. For more information about Stroke and Hcy,
please click this link: http://www.youtube.com/watch?v=HWC7dBS8qbI. Details
about enzyme cycling and Hcy test can be found online at www.diazyme.com.
Dr. Yuan received his Ph.D. from Kyushu University, Japan, specializing in
enzymology, and co-founded Diazyme Laboratories in 2000, focusing on
research and development of enzyme based novel clinical diagnostic reagents
and their commercialization.